Glenn L. Cooper M.D., Director at REPLIGEN CORP (RGEN), bought 5,000 shares at $4.98 ($25K) on 2009-11-09, disclosed to the SEC on 2009-11-17.
Open-market purchase of $25k RGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| RGEN | BUY | 2012-09-24 | $61K | — | Filing → |
| CNDO | BUY | 2012-06-26 | $53K | — | Filing → |
| IDEV | BUY | 2006-01-09 | $59K | — | Filing → |